financetom
Business
financetom
/
Business
/
Kinsale Capital Group Q4 Operating Earnings, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kinsale Capital Group Q4 Operating Earnings, Revenue Increase
Feb 13, 2025 1:56 PM

04:28 PM EST, 02/13/2025 (MT Newswires) -- Kinsale Capital Group ( KNSL ) reported Q4 operating earnings late Thursday of $4.62 per diluted share, up from $3.87 a year earlier.

Analysts polled by FactSet expected $4.36.

Revenue for the quarter ended Dec. 31 was $412.1 million, up from $351.2 million a year earlier.

Analysts surveyed by FactSet expected $416.7 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Nuvation Bio Says Taletrectinib Added as Preferred Agent in National Comprehensive Cancer Network for Lung Cancer
Nuvation Bio Says Taletrectinib Added as Preferred Agent in National Comprehensive Cancer Network for Lung Cancer
Jun 24, 2025
07:53 AM EDT, 06/24/2025 (MT Newswires) -- Nuvation Bio ( NUVB ) said Tuesday that taletrectinib has been added as a preferred agent in the updated National Comprehensive Cancer Network clinical practice guidelines for non-small cell lung cancer, or NSCLC. The guidance now supports taletrectinib as a treatment option for both first-line and subsequent therapy in ROS1-positive NSCLC, including for...
Vera Bradley Divests Pura Vida Bracelets Brand
Vera Bradley Divests Pura Vida Bracelets Brand
Jun 24, 2025
07:53 AM EDT, 06/24/2025 (MT Newswires) -- Vera Bradley's ( VRA ) consumer wearables brand Pura Vida Bracelets has been acquired by CriticalPoint, the financial firm said Tuesday. Additionally, Ryan Heuser, co-founder and former president of Paul Frank Industries, has joined Pura Vida as the company's new chief executive officer, effective immediately, CriticalPoint said. Financial terms of the transaction were...
InMed Says Preclinical Data Show INM-901 'Significantly' Reduces Neuroinflammation; Shares Jump
InMed Says Preclinical Data Show INM-901 'Significantly' Reduces Neuroinflammation; Shares Jump
Jun 24, 2025
07:52 AM EDT, 06/24/2025 (MT Newswires) -- InMed Pharmaceuticals ( INM ) said Tuesday that new preclinical data show that INM-901 significantly reduces inflammation in ex vivo models of neuroinflammation. The data demonstrate a statistically significant reduction of pro-inflammatory cytokines and levels of inflammasome marker NLRP3, supporting the potential of INM-901 as a therapeutic candidate for Alzheimer's disease, the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved